BioHarvest Sciences, a company that biosynthetically created grape and pomegranate extracts to sell to food ingredient companies and consumers, claims to have done the same with cannabis.
Delta-8 THC exploded onto the scene in 2019, followed by delta-10 THC, THC-O acetate and HHC in 2020 and 2021.
While state regulatory agencies have opted for a whack-a-mole approach that focuses on controlling one cannabinoid at a time, the federal government has been largely silent on the legal status of hemp-derived cannabinoids.
While many states responded to the delta-8 THC phenomenon by banning the cannabinoid, other markets sought to tame it by regulating D-8 products, mandating testing and enforcing other compliance standards.
In Louisiana, regulators and stakeholders hope this approach will reduce safety hazards and clear up confusion over which cannabinoid products can and can’t be sold in the state.
As research broke over the past two weeks that cannabis products such as CBD, cannabinoid acids and even synthetic cannabis compounds might prevent or treat COVID-19 infections, excitement among entrepreneurs spread.
Las Vegas-based GB Sciences is leaving the cannabis cultivation space to pursue further interests in the biopharmaceutical industry.
Cannabis operators making or selling delta-8 THC are pointing to two recent comments from U.S. Drug Enforcement Administration officials that suggest states lining up to ban the isomer might be going too far
New products are hitting shelves as delta-8 THC bans in a number of states cause manufacturers and retailers to pivot away from the popular compound and try to make up sales.
With state limits on hemp-derived delta-8 THC beginning to impact sales for product manufacturers and retailers, businesses are considering how they will make up the gap.
In an effort to boost a CBD-slumped economy, hemp producers are synthesizing delta-8 THC.
The Kentucky Hemp Association claims that state police are illegally raiding legal hemp retail stores as they look for delta-8 THC products and is asking a state judge to put a stop to the practice.
Sales and demand for runaway market hit delta-8 THC took regulators by surprise over the past year, so state lawmakers are working to create a distinction and rules around cannabis that intoxicates versus cannabis that doesn’t.
